Weng W, Huang H
Heliyon. 2024; 10(17):e36531.
PMID: 39296205
PMC: 11409029.
DOI: 10.1016/j.heliyon.2024.e36531.
Cheng X, Wu L
Inflammopharmacology. 2024; 32(5):3443-3459.
PMID: 39207637
DOI: 10.1007/s10787-024-01554-4.
Zhu W, Mao S, Jiang J
Cell Div. 2024; 19(1):26.
PMID: 39192251
PMC: 11351637.
DOI: 10.1186/s13008-024-00130-0.
Liu L, Wu J, Lu C, Ma Y, Wang J, Xu J
J Transl Med. 2024; 22(1):499.
PMID: 38796415
PMC: 11128115.
DOI: 10.1186/s12967-024-05330-4.
Yifan M, Rui X, Yuan L, Feiyun J
Food Sci Nutr. 2024; 12(4):2523-2536.
PMID: 38628206
PMC: 11016449.
DOI: 10.1002/fsn3.3935.
LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
Yang T, Tian S, Zhao J, Pei M, Zhao M, Yang X
Cell Cycle. 2023; 22(23-24):2538-2551.
PMID: 38146687
PMC: 10936639.
DOI: 10.1080/15384101.2023.2297591.
Disulfidptosis-associated LncRNAs index predicts prognosis and chemotherapy drugs sensitivity in cervical cancer.
Liu L, Liu J, Lyu Q, Huang J, Chen Y, Feng C
Sci Rep. 2023; 13(1):12470.
PMID: 37528124
PMC: 10394072.
DOI: 10.1038/s41598-023-39669-3.
A novel necroptosis-related long non-coding RNA signature predicts prognosis and immune response in cervical cancer patients.
Kong X, Xiong Y
J Cancer Res Clin Oncol. 2023; 149(14):12947-12964.
PMID: 37466792
DOI: 10.1007/s00432-023-05158-3.
Insights into the Role of LncRNAs and miRNAs in Glioma Progression and Their Potential as Novel Therapeutic Targets.
Kciuk M, Yahya E, Mohamed M, Abdulsamad M, Allaq A, Gielecinska A
Cancers (Basel). 2023; 15(13).
PMID: 37444408
PMC: 10340789.
DOI: 10.3390/cancers15133298.
lncRNA ASBEL and lncRNA Erbb4-IR reduce chemoresistance against gemcitabine and cisplatin in stage IV lung squamous cell carcinoma via the microRNA-21/LZTFL1 axis.
Liang Z, Zhang Z, Sun G, Zhao B, Xin G, Zhang L
Am J Cancer Res. 2023; 13(6):2732-2750.
PMID: 37424811
PMC: 10326598.
LncRNA SNHG1 Accelerates Cell Proliferation, Migration, and Invasion of Hepatoblastoma Through Mediating miR-6838-5p/PIM3/RhoA Axis.
Zhang T, Ji C, Zhang Y, Yuan M, Gao H, Yin Q
Biochem Genet. 2023; 62(1):59-76.
PMID: 37248373
DOI: 10.1007/s10528-023-10404-x.
Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer.
Huang P, Wang L, Wang Y, Tsai M, Lin T, Liao C
Cells. 2023; 12(6).
PMID: 36980210
PMC: 10047572.
DOI: 10.3390/cells12060869.
Downregulation of lncRNA in hypoxia and stem cells is associated with poor disease prognosis in gliomas.
Gandhi S, Bhushan A, Shukla U, Pundir A, Singh S, Srivastava T
Cell Cycle. 2023; 22(9):1135-1153.
PMID: 36945177
PMC: 10081076.
DOI: 10.1080/15384101.2023.2191411.
Therapeutic Effects of Coumarins with Different Substitution Patterns.
Flores-Morales V, Villasana-Ruiz A, Garza-Veloz I, Gonzalez-Delgado S, Martinez-Fierro M
Molecules. 2023; 28(5).
PMID: 36903660
PMC: 10005689.
DOI: 10.3390/molecules28052413.
LINC01012 upregulation promotes cervical cancer proliferation and migration via downregulation of CDKN2D.
Zhang K, Ni X, Ma X, Sun R, Qiu J, Luo C
Oncol Lett. 2023; 25(3):124.
PMID: 36844616
PMC: 9950337.
DOI: 10.3892/ol.2023.13710.
Functional Relevance of the Long Intergenic Non-Coding RNA Regulator of Reprogramming (Linc-ROR) in Cancer Proliferation, Metastasis, and Drug Resistance.
Pena-Flores J, Enriquez-Espinoza D, Muela-Campos D, Alvarez-Ramirez A, Saenz A, Barraza-Gomez A
Noncoding RNA. 2023; 9(1).
PMID: 36827545
PMC: 9965135.
DOI: 10.3390/ncrna9010012.
lncRNA TPT1-AS1 promotes cell migration and invasion in esophageal squamous-cell carcinomas by regulating the miR-26a/HMGA1 axis.
Cheng W, Yang F, Ma Y
Open Med (Wars). 2023; 18(1):20220533.
PMID: 36820066
PMC: 9938642.
DOI: 10.1515/med-2022-0533.
Cancer and Alzheimer's Inverse Correlation: an Immunogenetic Analysis.
Bhardwaj A, Liyanage S, Weaver D
Mol Neurobiol. 2023; 60(6):3086-3099.
PMID: 36797545
DOI: 10.1007/s12035-023-03260-8.
SNHG1 functions as a ceRNA in hypertrophic scar fibroblast proliferation and apoptosis through miR-320b/CTNNB1 axis.
Li Q, Zhang B, Lu J, Wa Q, He M, Xie L
Arch Dermatol Res. 2023; 315(6):1593-1601.
PMID: 36754869
DOI: 10.1007/s00403-022-02516-y.
Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer.
Wang Q, Xu Y
Front Pharmacol. 2022; 13:1065701.
PMID: 36532719
PMC: 9747936.
DOI: 10.3389/fphar.2022.1065701.